New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis Malignant mesothelioma is not only one of the rare...
Swedish Mesothelioma Rates Unaffected By Asbestos Ban
Swedish Mesothelioma Rates Unaffected By Asbestos Ba n The asbestos ban instituted in Sweden more than 30 years ago had still not ha...
New Mesothelioma Immunotherapies Target Key Protein
New Mesothelioma Immunotherapies Target Key Protein The cell-surface glycoprotein mesothelin is poised to be a key part of several n...
Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival
Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival There has been some encouraging news this month for patients sufferi...
